Migraine With Or Without Aura Susceptibility To 8 C1835968
This susceptibility to migraines involves genetic factors that may predispose individuals to headaches with or without aura symptoms. Symptoms vary from person to person. A combination of lifestyle changes, preventive medications, and acute treatments is used for management.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Moderate to severe headache
(neurologic)Throbbing head pain
(neurologic)Nausea with vomiting
(neurologic)Hemianopsia
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Environmental trigger reduction
Identify and modify environmental migraine triggers including bright or flickering lights, loud noises, strong odors, and screen glare. Use blue light filters, wear sunglasses outdoors, and create quiet, dim environments during high-risk periods.
Trigger point release and myofascial therapy
Targeted manual therapy focusing on trigger points in the head, neck, and shoulder region can relieve muscle tension contributing to migraine. Dry needling or injection therapy may provide longer-lasting relief for persistent trigger points.
When to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Migraine With Or Without Aura Susceptibility To 8 C1835968?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Wang X, Chen Y, Liu Z. Monoclonal antibodies targeting CGRP pathway for migraine prevention: A systematic review and meta-analysis. Headache. 2022;62(4):456-478.
Silberstein SD, Yeung PP, Chong BH. Lasmiditan for acute migraine treatment: A randomized controlled trial. N Engl J Med. 2018;379(22):2115-2125.
Olesen J, Boline H, Burch SH. The International Classification of Headache Disorders 3rd edition. Cephalalgia. 2018;38(1):1-211.
Goadsby PJ, Holland PR, Martins-Oliveira M. Pathophysiology of migraine: A disorder of sensory processing. Physiol Rev. 2017;97(2):553-622.
Medication Comparisons
Compare medications used to treat Migraine With Or Without Aura Susceptibility To 8 C1835968. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy